Health Care Checkup

April 4, 2025

THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Wednesday, Senate Republicans released their version of the House budget resolution text. The Senate voted on Thursday to proceed to the resolution and will conduct a “vote-a-rama,” with floor votes expected to go through the evening and into Saturday.


On Thursday, the Senate confirmed Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS) in a 53 - 45 party-line vote.


On Thursday, the Senate Judiciary Committee held a markup on five drug patent bills and one pharmacy benefit managers (PBM) bill, advancing all six bills to the full Senate by voice vote: S.527, the Prescription Pricing for the People Act of 2025; S.1040, the Drug Competition Enhancement Act; S.1041, to amend title 35, United States Code, to address the infringement of patents that claim biological products; S.1097, the Interagency Patent Coordination and Improvement Act of 2025; S.1095, the Stop STALLING Act; S.1096, the Preserve Access to Affordable Generics and Biosimilars Act.


On Thursday, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the department plans to reinstate some of the employees and programs cut during the Trump administration’s overhaul of federal agencies.

What to Expect Next Week:



The House is expected to take up the Senate passed budget resolution prior to the April recess, if the Senate is successful in passing it this weekend.

 

The House Energy and Commerce Committee will hold a markup on a slate of bills, including several health care bills, on Tuesday. The Ways and Means Committee will also hold a hearing on biosimilars on Tuesday.

 

The Senate Health, Education, Labor and Pensions (HELP) Committee will also hold a markup that includes one health care bill, the Give Kids a Chance Act of 2025, on Wednesday. 

DEEP DIVE

Congressional:


Senate Republicans Unveil Retooled Budget Blueprint

On Wednesday, Senate Republicans released their version of the budget resolution. The Senate voted on Thursday to proceed to the resolution and will conduct a “vote-a-rama,” with floor votes expected to go through the evening and into Saturday. The Senate budget resolution instructs various committees to commit to billions of dollars in deficit reduction. The Senate Finance Committee cannot increase the deficit by more than $1.5 trillion within the budget window. The Senate Health, Education, Labor, and Pensions (HELP) Committee is directed to find $1 billion in savings. The resolution would also include a $5 trillion increase of the debt ceiling. If the Senate is successful in passing the resolution the House is expected to take it up prior to the April recess. Both chambers need to adopt identical budget resolutions before they can draft and pass a reconciliation bill. Read the Senate budget resolution text here and a summary here.

 

Senate Confirms Dr. Oz to Lead CMS

On Thursday, the Senate confirmed Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS) in a 53 - 45 party-line vote. Oz will oversee more than $1.5 trillion in federal spending across Medicare, Medicaid, and the Affordable Care Act’s insurance exchanges. Oz will face pressing regulatory decisions as early as next week, as a final rule outlining payment rates for Medicare Advantage plans is expected in early April. The rule, first proposed in January, calls for a 4.3 percent increase in payments for 2026, reversing the slight cuts in 2025 and 2024.

 

House Energy and Commerce Subcommittee on Oversight and Investigations Holds Hearing on Cybersecurity Vulnerabilities in Legacy Medical Devices

On Tuesday, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing on cybersecurity vulnerabilities in legacy medical devices. Witnesses highlighted the risks posed by outdated devices, including threats to patient safety and healthcare infrastructure, and emphasized the need for enhanced regulatory oversight, workforce support, and updated cybersecurity practices. Democrats primarily highlighted the potential impacts of HHS funding and staffing cuts on reviewing and regulating medical devices, while Republicans focused on ensuring the improved cybersecurity resilience of the devices. Read Mehlman’s hearing summary here.

 

The Senate Judiciary Committee Advances Six Drug Pricing Bills in Markup

On Thursday, the Senate Judiciary Committee held a markup on five drug patent bills and one pharmacy benefit managers (PBM) bill, advancing all six bills to the full Senate by voice vote:

  • S.527, the Prescription Pricing for the People Act of 2025
  • S.1040, the Drug Competition Enhancement Act
  • S.1041, to amend title 35, United States Code, to address the infringement of patents that claim biological products
  • S.1097, the Interagency Patent Coordination and Improvement Act of 2025
  • S.1095, the Stop STALLING Act
  • S.1096, the Preserve Access to Affordable Generics and Biosimilars Act

Read brief summaries of all 6 bills here.

 

Senate HELP Chair Cassidy, Ranking Member Sanders Invite HHS Secretary Kennedy to Committee Hearing on HHS Reorganization

On Tuesday, Senators Bill Cassidy, M.D. (R-LA), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, and Bernie Sanders (I-VT), ranking member of the HELP Committee, sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., inviting him to testify on April 10, 2025, before the HELP Committee at a hearing titled “An Update on the Restructuring of the Department of Health and Human Services.” Please find the press release here and the letter here. Secretary Kennedy recently announced a major reorganization of the Department, including about 20,000 in total reductions in force. 


Senate and House Democrats Demand Answers on HHS Layoffs

On Tuesday, Senate Democrats, led by Senators Warner (D-MA), Wyden (D-OR), Sanders (I-VT), Schumer (D-NY), and 34 members of the Senate Democratic caucus, sent a letter to Robert F. Kennedy Jr., the Secretary of the Department of Health and Human Services (HHS), criticizing mass layoffs of federal health workers. The senators condemned the firings as reckless, warning of severe consequences for public health, particularly for vulnerable communities. The letter highlighted the dismantling of key health agencies and the lack of transparency regarding the administration’s actions. The senators urged a reversal of these cuts, citing risks to seniors, children, medical research, and overall access to health care. Read the press release and letter here.

 

House Energy and Commerce Committee Democratic leaders also sent a letter to Kennedy asking for answers regarding HHS’s 25% reduction in workforce. The letter was signed by Ranking Member Frank Pallone, Jr. (D-NJ), Health Subcommittee Ranking Member Diana DeGette (D-CO), and Oversight and Investigations Subcommittee Ranking Member Yvette Clarke (D-NY). Read the press release here and the letter here. 

 

CBO Releases Latest Long-Term Budget Outlook

Late last week, on Friday, the Congressional Budget Office (CBO) released its latest report on projections for the federal budget and the economy over the next 30 years, assuming current laws remain generally unchanged. In the CBO’s latest projections, the Hospital Insurance (HI) Trust Fund is expected to be exhausted in 2052, which is 17 years later than the previous projection. The HI Trust Fund is used to pay for benefits under Medicare Part A, which covers inpatient hospital services, care provided in skilled nursing facilities, home health care, and hospice care. The CBO now projects that expenditures from the trust fund will be smaller and income to the trust fund will be greater than it projected last year. Read the full explanation in Box 2-1 of the report here. 


Notable Bills Introduced:


Senators Schatz, Wicker Lead Bipartisan Group Of 60 Senators in Introducing Legislation to Expand Telehealth Access, Make Permanent Telehealth Flexibilities

On Thursday, Senators Brian Schatz (D-HI), Roger Wicker (R-MS), Mark Warner (D-VA), Cindy Hyde-Smith (R-MS), Peter Welch (D-VT), and John Barrasso (R-WY) led a bipartisan group of 60 senators in reintroducing the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. The CONNECT for Health Act will expand coverage of telehealth services through Medicare, making COVID-19 telehealth flexibilities permanent. Current flexibilities are set to expire on September 30 unless Congress extends them. Read the press release here and the bill here.


Representatives Arrington and Salinas Introduce Bipartisan Bill to Increase Rural Access to Specialty Care

On Thursday, House Budget Committee Chairman Jodey Arrington (R-TX) and Representative Andrea Salinas (D-OR) introduced the Ensuring Access to Specialty Care Everywhere (EASE) Act, legislation to increase rural access to specialty care providers by authorizing the Center of Medicare and Medicaid Innovation (CMMI) to create a virtual specialty care provider network that rural patients enrolled in Medicare, Medicaid, or CHIP can access through telehealth. Companion legislation in the Senate was led by Senators Markwayne Mullin (R-OK) and Alex Padilla (D-CA). Read the press release here and the bill here.


Senators Rounds and Welch Introduce Legislation to Prevent Rural Hospital Closure

On Thursday, Senators Mike Rounds (R-SD) and Peter Welch (D-VT) introduced legislation to support rural hospitals at risk of closure. The Rural Hospital Technical Assistance Program Act would codify an existing pilot program administered by the U.S. Department of Agriculture (USDA) that provides technical assistance to rural hospitals to prevent closures, improve their financial and operational performance, and strengthen essential healthcare services in rural communities. Read the press release here and the bill here.

 

Senators Mullin, Padilla, Tillis Introduce the Ensuring Access to Specialty Care Everywhere Act

On Wednesday, Senators Markwayne Mullin (R-OK), Alex Padilla (D-CA), and Thom Tillis (R-NC) introduced the Ensuring Access to Specialty Care Everywhere (EASE) Act, which would increase access to specialty care for rural and underserved Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) patients. Companion legislation was introduced in the House by Representatives Jodey Arrington (R-TX-19) and Andrea Salinas (D-OR-06). Read the press release here and the bill here.

 

Representative Walberg Introduces Legislation to Expand Health Care for Small Businesses

On Tuesday, House Education and Workforce Committee Chairman Tim Walberg (R-MI) re-introduced the Association Health Plans Act. The legislation would codify a 2018 Trump administration rule, later rescinded by the Biden administration, that expanded association health plans (AHPs) by enabling a broader group of small businesses, including self-employed individuals, to be eligible to form AHPs. Read the press release here and the bill here.

 

Senators Markey and Capito Reintroduce Bipartisan Legislation to Alleviate Administrative Burden for Caregivers

On Monday, Senators Edward Markey (D-MA), Ranking Member of the Health, Education, Labor, and Pensions (HELP) Subcommittee on Primary Health and Retirement Security and Shelley Moore Capito (R-WV) reintroduced the Alleviating Barriers for Caregivers (ABC) Act, bipartisan legislation that would require the Centers for Medicare and Medicaid Services (CMS), Social Security Administration (SSA), and Children’s Health Insurance Program (CHIP) to review their eligibility, processes, procedures, forms, and communications to reduce the administrative burden on family caregivers. Companion legislation was reintroduced in the House by Representatives Seth Magaziner (D-RI-02) and Kat Cammack (R-FL-03). Read the press release here and the bill here.

 

Senators Welch, Blackburn, King Introduce Bicameral States Handling Access to Reciprocity for Employment (SHARE) Act to Improve Interstate Health Care Workforce Licensing

Late last week, Senators Peter Welch (D-VT), Marsha Blackburn (R-TN), and Angus King (I-ME) introduced the States Handling Access to Reciprocity for Employment (SHARE) Act, bipartisan legislation to improve interstate health care workforce licensing. The legislation amends existing federal law to authorize the FBI to conduct criminal background checks for state licensing agencies and reduce bureaucratic red tape. The bill also ensures that criminal history record information is maintained in the same manner as requests for all occupational licenses handled at the state level. Companion legislation was introduced in the House by Representatives Tracey Mann (R-KS-01) and Joe Neguse (D-CO-02). Read the press release here and the bill here.

 

Representatives Swalwell and Crenshaw Introduce Bipartisan Legislation to Prevent Adverse Drug Effects

Late last week, Representatives Dan Crenshaw (R-TX-02) and Eric Swalwell (D-CA-14) introduced the Right Drug Dose Now Act, bipartisan legislation that would enable the use of evidence-based pharmacogenomic (PGx) testing to prevent adverse drug events and help ensure that patients receive medications tailored to their genetic makeup. The bill would update the National Action Plan for Adverse Drug Event Prevention by integrating advancements in pharmacogenomic research and testing. Read the press release here and the bill here. 


Executive Branch:



HHS May Reinstate Some Recently Cut Employees and Programs, Sends Memo to Hill Staff Explaining Cuts

On Thursday, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced that the department plans to reinstate some of the employees and programs cut during the Trump administration’s overhaul of federal agencies. Speaking alongside Agriculture Secretary Brooke Rollins at an elementary school in Alexandria, Virginia, Kennedy acknowledged that mistakes were inevitable in such a large-scale reorganization. “At DOGE, we talked about this from the beginning ... we're going to do 80 percent cuts, but 20 percent of those are going to have to be reinstalled because we'll make mistakes,” he said. “If we make mistakes, we're going to admit it and we're going to remedy it.”

 

At the same time, HHS circulated a memo to lawmakers explaining the rationale behind the recent workforce reductions. The document, obtained by POLITICO, highlights overlapping roles and administrative inefficiencies, noting that HHS had 41 chief information officers across just 28 divisions, in addition to numerous IT and HR departments, 1,400 external affairs officers, and 100 communication offices. The memo confirmed that about 10,000 employees were affected in the latest round of staffing reductions, bringing total HHS employment to around 62,000 — a 25% decrease since the start of the current administration. The memo also stated the reorganization is aimed at streamlining operations, including consolidating public health agencies into a new Administration for a Healthy America, refocusing the CDC on infectious disease control, reducing waste in Medicare and Medicaid, and improving coordination across research, community services, and food and drug oversight. Read the memo here.

 

Justice Department Launches Anticompetitive Regulations Task Force

Late last week, the Justice Department launched an Anticompetitive Regulations Task Force to advocate for the elimination of anticompetitive state and federal laws and regulations that “undermine free market competition and harm consumers, workers, and businesses.” The Division will seek information from the public about laws and regulations that make it more difficult for businesses to compete effectively, especially in markets that have the greatest impact on American households, including Healthcare. The memo stated that laws and regulations in healthcare markets “too often discourage doctors and hospitals from providing low-cost, high-quality healthcare and instead encourage overbilling and consolidation.” Public comments are due by May 26, 2025. Read the press release here.

 

FDA Clears At-Home Test for STIs

Late last week, the Food and Drug Administration approved the first at-home test to detect gonorrhea, chlamydia, and trichomoniasis. The test, manufactured by Visby Medical, can be purchased without a prescription and delivers results in about 30 minutes, according to an FDA press release. The FDA has authorized marketing for other at-home sexually transmitted infections (STI) tests in recent years. In 2023, the agency authorized the first at-home test for chlamydia and gonorrhea, and last year authorized the first at-home syphilis test. Read the press release here. 


Legal & Other:


States Sue HHS Over $11 Billion Cut in Public Health Funds 

On Tuesday, 23 states and the District of Columbia filed a lawsuit in the U.S. District Court for the District of Rhode Island, arguing that the Department of Health and Human Services' (HHS) $11 billion in cuts allocated to states for public health, mental health, and addiction services is unlawful. The complaint stated that the cuts announced on March 24, with no advance warning, would have devastating consequences for communities throughout the country as the money funds health departments’ core functions, including vaccinations and disease tracking and testing programs. The sole basis provided for the withdrawal, according to the states, was that the government initially appropriated the money through COVID-19-related laws. The states argued the funding terminations exceed the agency’s statutory and regulatory authority and are unlawful under the Administrative Procedure Act. The states are seeking a temporary restraining order, as well as preliminary and permanent injunctions, to restore the funds. Read the complaint here.

 

Judge Rules FDA Lacks Authority to Regulate Laboratory Tests

On Monday, Judge Sean D. Jordan of the U.S. District Court for the Eastern District of Texas ruled that the Food and Drug Administration (FDA) rule, which allowed it to oversee lab-developed tests (LDTs) originating from a single laboratory, exceeds its authority and is unlawful. The FDA finalized a rule in May 2024 that labeled LDTs as medical devices under the Federal Food, Drug, and Cosmetic Act. The American Clinical Laboratory Association and the Association for Molecular Pathology filed the suit. Jordan wrote in the order that “The final rule will initially impact nearly 80,000 existing tests offered by almost 1,200 laboratories, and it will also affect about 10,013 new tests offered every year going forward.” The court order now vacates and sends the FDA’s final rule back to the agency. It’s unclear how the Trump administration will approach regulation on LDTs but the administration defended the FDA’s authority in oral arguments on February 19. Read the ruling here. 

CONGRESSIONAL HEARINGS & EVENTS

House:


House Committee on Appropriations, Subcommittee on National Security, Department of State, and Related Programs – Hearing

“Assessing the President’s Emergency Plan for AIDS Relief (PEPFAR)”

Tuesday, April 8, at 8:00 AM

 

House Committee on Ways and Means, Subcommittee on Health – Hearing

“Lowering Costs for Patients: The Health of the Biosimilar Market”

Tuesday, April 8, at 10:00 AM

 

House Energy and Commerce Committee – Markup

“Full Committee: Markup” See the bills here.

Tuesday, April 8, at 10:00 AM


Senate:


Senate Health, Education, Labor, and Pensions Committee – Markup

“Markup of S. 558, Antisemitism Awareness Act of 2025; S. 163, Protecting Students on Campus Act of 2025; S. 932, Give Kids a Chance Act of 2025.”

Wednesday, April 9, at 10:00 AM

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258